Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Recombinant porcine factor VIII (B domain deleted)

EU orphan designation number: EU/3/10/784
Active ingredient: Recombinant porcine factor VIII (B domain deleted)
Indication: Treatment of haemophilia A
Sponsor: Baxalta Innovations GmbH
Industriestrasse 67, A-1221 Wien, Österreich

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/09/2010 Orphan designation EMA/OD/043/10 (2010)6651 of 20/09/2010
19/07/2013 Transfer of orphan designation EMA/OD/043/10/T/01 (2013)4742 of 17/07/2013
28/05/2015 Change of name and/or address of sponsor
23/10/2015 Removal of orphan designation from Community Register